Mutant monocyte chemoattractant protein 1 protein attenuates migration of and inflammatory cytokine release by macrophages exposed to orthopedic implant wear particles
- 7 October 2013
- journal article
- research article
- Published by Wiley in Journal of Biomedical Materials Research Part A
- Vol. 102 (9) , 3291-3297
Abstract
Wear particles generated from total joint replacements can stimulate macrophages to release chemokines, such as monocyte chemoattractant protein 1 (MCP‐1), which is the most important chemokine regulating systemic and local cell trafficking and infiltration of monocyte/macrophages in chronic inflammation. One possible strategy to curtail the adverse events associated with wear particles is to mitigate migration and activation of monocyte/macrophages. The purpose of this study is to modulate the adverse effects of particulate biomaterials and inflammatory stimuli such as endotoxin by interfering with the biological effects of the chemokine MCP‐1. In the current study, the function of MCP‐1 was inhibited by the mutant MCP‐1 protein called 7ND, which blocks its receptor, the C–C chemokine receptor type 2 (CCR2) on macrophages. Addition of 7ND decreased MCP‐1‐induced migration of THP‐1 cells in cell migration experiments in a dose‐dependent manner. Conditioned media from murine macrophages exposed to clinically relevant polymethylmethacrylate (PMMA) particles with/without endotoxin [lipopolysaccharide (LPS)] had a chemotactic effect on human macrophages, which was decreased dramatically by 7ND. 7ND demonstrated no adverse effects on the viability of macrophages, and the capability of mesenchymal stem cells (MSCs) to form bone at the doses tested. Finally, proinflammatory cytokine production was mitigated when macrophages were exposed to PMMA particles with/without LPS in the presence of 7ND. Our studies confirm that the MCP‐1 mutant protein 7ND can decrease macrophage migration and inflammatory cytokine release without adverse effects at the doses tested. Local delivery of 7ND at the implant site may provide a therapeutic strategy to diminish particle‐associated periprosthetic inflammation and osteolysis. © 2013 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 102A: 3291–3297, 2014.Keywords
Funding Information
- NIH (1-R01-AR063717-01)
This publication has 33 references indexed in Scilit:
- Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activationJournal of Orthopaedic Research, 2012
- Selective inhibition of the MCP‐1‐CCR2 ligand‐receptor axis decreases systemic trafficking of macrophages in the presence of UHMWPE particlesJournal of Orthopaedic Research, 2011
- Role of the Toll-like receptor pathway in the recognition of orthopedic implant wear-debris particlesBiomaterials, 2011
- Effects of orthopedic polymer particles on chemotaxis of macrophages and mesenchymal stem cellsJournal of Biomedical Materials Research Part A, 2010
- Systemic trafficking of macrophages induced by bone cement particles in nude miceBiomaterials, 2008
- The combined role of wear particles, macrophages and lymphocytes in the loosening of total joint prosthesesJournal of The Royal Society Interface, 2008
- PMMA particle‐mediated DNA vaccine for cervical cancerJournal of Biomedical Materials Research Part A, 2008
- Polymethylmethacrylate particles stimulate bone resorption of mature osteoclasts in vitroActa Orthopaedica, 2008
- G-protein activity requirement for polymethylmethacrylate and titanium particle-induced fibroblast interleukin-6 and monocyte chemoattractant protein-1 releasein vitroJournal of Biomedical Materials Research, 2000
- IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses.Journal of Clinical Investigation, 1998